Chaitali Dutta

Chaitali Dutta is an experienced pharmacology professional currently serving as Director of Pharmacology at Prime Medicine, Inc. since January 2024. Previously, Chaitali held various leadership positions at Verve Therapeutics from January 2020 to June 2023, including Associate Director of Preclinical Pharmacology and Principal Scientist. Chaitali's career also includes roles as Senior Scientist at PureTech Health, Scientist II and Scientist I at Dicerna Pharmaceuticals, Research Fellow at AstraZeneca, and Post Doctoral Fellow at Dana-Farber Cancer Institute. Chaitali's expertise encompasses in vivo study management, drug delivery platforms using milk exosomes, and the development of disease models for rare liver diseases, among other significant contributions. Chaitali earned a PhD in Biomedical Sciences from UMass Chan Medical School in 2008.